Amoxicillin precautions: Difference between revisions
No edit summary |
m Protected "Amoxicillin precautions" ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{CMG}} | {{CMG}} | ||
==List of | ==List of precautions== | ||
<font size="4">[[Amoxicillin side effects#Drug/Laboratory Test Interactions|Drug/Laboratory Test Interactions]]</font> | <font size="4">[[Amoxicillin side effects#Drug/Laboratory Test Interactions|Drug/Laboratory Test Interactions]]</font> | ||
<br> | <br> | ||
Line 7: | Line 7: | ||
<br> | <br> | ||
<br> | <br> | ||
<font size="4">[[Amoxicillin | <font size="4">[[Amoxicillin precautions#Pregnancy|Pregnancy]]</font> | ||
<br> | <br> | ||
<br> | <br> | ||
<font size="4">[[Amoxicillin | <font size="4">[[Amoxicillin precautions#Labor and Delivery|Labor and Delivery]]</font> | ||
<br> | <br> | ||
<br> | <br> | ||
<font size="4">[[Amoxicillin | <font size="4">[[Amoxicillin precautions#Nursing Mothers|Nursing Mothers]]</font> | ||
<br> | <br> | ||
<br> | <br> | ||
<font size="4">[[Amoxicillin | <font size="4">[[Amoxicillin precautions#Pediatric Use|Pediatric Use]]</font> | ||
<br> | <br> | ||
---- | ---- | ||
Line 26: | Line 26: | ||
Following administration of ampicillin to pregnant women, a transient decrease in plasma | Following administration of ampicillin to pregnant women, a transient decrease in plasma | ||
concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol | concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol | ||
has been noted. This effect may also occur with amoxicillin. ''[[Amoxicillin | has been noted. This effect may also occur with amoxicillin. ''[[Amoxicillin precautions#List of precautions|Return to top]]'' | ||
<br> | <br> | ||
===Carcinogenesis, Mutagenesis, Impairment of Fertility=== | ===Carcinogenesis, Mutagenesis, Impairment of Fertility=== | ||
Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of amoxicillin alone have not been conducted; however, the following information is available from tests on a 4:1 mixture of amoxicillin and potassium clavulanate (AUGMENTIN). AUGMENTIN was non-mutagenic in the Ames bacterial mutation assay, and the yeast gene | Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of amoxicillin alone have not been conducted; however, the following information is available from tests on a 4:1 mixture of amoxicillin and potassium clavulanate (AUGMENTIN). AUGMENTIN was non-mutagenic in the Ames bacterial mutation assay, and the yeast gene | ||
conversion assay. ''[[Amoxicillin | conversion assay. ''[[Amoxicillin precautions#List of precautions|Return to top]]'' | ||
<br> | <br> | ||
===Pregnancy=== | ===Pregnancy=== | ||
Line 38: | Line 38: | ||
adequate and well-controlled studies in pregnant women. Because animal reproduction studies | adequate and well-controlled studies in pregnant women. Because animal reproduction studies | ||
are not always predictive of human response, this drug should be used during pregnancy only if | are not always predictive of human response, this drug should be used during pregnancy only if | ||
clearly needed. ''[[Amoxicillin | clearly needed. ''[[Amoxicillin precautions#List of precautions|Return to top]]'' | ||
<br> | <br> | ||
===Labor and Delivery=== | ===Labor and Delivery=== | ||
Line 47: | Line 47: | ||
delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or | delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or | ||
increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of | increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of | ||
the newborn will be necessary. ''[[Amoxicillin | the newborn will be necessary. ''[[Amoxicillin precautions#List of precautions|Return to top]]'' | ||
<br> | <br> | ||
===Nursing Mothers=== | ===Nursing Mothers=== | ||
Penicillins have been shown to be excreted in human milk. Amoxicillin use | Penicillins have been shown to be excreted in human milk. Amoxicillin use | ||
by nursing mothers may lead to sensitization of infants. Caution should be exercised when | by nursing mothers may lead to sensitization of infants. Caution should be exercised when | ||
amoxicillin is administered to a nursing woman. ''[[Amoxicillin | amoxicillin is administered to a nursing woman. ''[[Amoxicillin precautions#List of precautions|Return to top]]'' | ||
<br> | <br> | ||
===Pediatric Use=== | ===Pediatric Use=== | ||
Because of incompletely 313 developed renal function in neonates and young | Because of incompletely 313 developed renal function in neonates and young | ||
314 infants, the elimination of amoxicillin may be delayed. Dosing of AMOXIL should be modified | 314 infants, the elimination of amoxicillin may be delayed. Dosing of AMOXIL should be modified | ||
315 in pediatric patients 12 weeks or younger (≤3 months). ''[[Amoxicillin | 315 in pediatric patients 12 weeks or younger (≤3 months). ''[[Amoxicillin precautions#List of precautions|Return to top]]'' | ||
<br> | <br> | ||
<br> | <br> |
Latest revision as of 17:34, 20 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
List of precautions
Drug/Laboratory Test Interactions
Carcinogenesis, Mutagenesis, Impairment of Fertility
Pregnancy
Labor and Delivery
Nursing Mothers
Pediatric Use
Drug/Laboratory Test Interactions
High urine concentrations of ampicillin may result in
false-positive reactions when testing for the presence of glucose in urine using CLINITEST®, Benedict’s Solution, or Fehling’s Solution. Since this effect may also occur with amoxicillin, it is recommended that glucose tests based on enzymatic glucose oxidase reactions (such as
CLINISTIX®) be used.
Following administration of ampicillin to pregnant women, a transient decrease in plasma
concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol
has been noted. This effect may also occur with amoxicillin. Return to top
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of amoxicillin alone have not been conducted; however, the following information is available from tests on a 4:1 mixture of amoxicillin and potassium clavulanate (AUGMENTIN). AUGMENTIN was non-mutagenic in the Ames bacterial mutation assay, and the yeast gene
conversion assay. Return to top
Pregnancy
Teratogenic Effects: Pregnancy Category B. Reproduction studies have been
performed in mice and rats at doses up to 10 times the human dose and have revealed no
evidence of impaired fertility or harm to the fetus due to amoxicillin. There are, however, no
adequate and well-controlled studies in pregnant women. Because animal reproduction studies
are not always predictive of human response, this drug should be used during pregnancy only if
clearly needed. Return to top
Labor and Delivery
Oral ampicillin-class antibiotics are poorly absorbed during labor.
Studies in guinea pigs showed that intravenous administration of ampicillin slightly decreased
the uterine tone and frequency of contractions but moderately increased the height and duration
of contractions. However, it is not known whether use of amoxicillin in humans during labor or
delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or
increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of
the newborn will be necessary. Return to top
Nursing Mothers
Penicillins have been shown to be excreted in human milk. Amoxicillin use
by nursing mothers may lead to sensitization of infants. Caution should be exercised when
amoxicillin is administered to a nursing woman. Return to top
Pediatric Use
Because of incompletely 313 developed renal function in neonates and young
314 infants, the elimination of amoxicillin may be delayed. Dosing of AMOXIL should be modified
315 in pediatric patients 12 weeks or younger (≤3 months). Return to top
Adapted from the FDA Package Insert.